|
"The Fundamentals of the Bioscience Industry
program provides the broad context of the pharmaceutical, biotech
and medical device sectors to students and young industry professionals.
The program is a good external complement to internal industry on-boarding
programs for new hires."
Ramana Sonty, PhD, Director, Neuroscience Project Management at Wyeth Pharmaceuticals
Former Senior Director/Team
Leader Global Project Management
NY, Pfizer Inc.
“As a scientist who moved to the business
environment, I see a critical need for programs like these which
introduce graduate students and post-docs to the business of biotechnology.
Employing an alumnus of the program as an intern was a very rewarding
experience for us. The Ruth Group provides strategic investor and
public relations services to biotech, pharmaceutical, and healthcare
organizations. We found that the intern had a deeper knowledge of
the industry which is usually lacking from persons with a basic
science education. He was able to integrate well into our team and
engage effectively in activities including messaging, writing of
both business and scientific documents and outreach to investors
and financial media.”
Cynthia Isaac, PhD, Vice President
Ogilvy Public Relations Worldwide
“The effectiveness of a well-rounded employee
is further developed by the Fundamentals of the Bioscience Industry
program. This program helps in the development of an
employee to understand all aspects leading to the customer at the
end. They learn that their position and department are just one
part of the whole picture to get quality products to the end user.”
Jonathan Klein, Vice President
of Operations
AGI Dermatics
“The feedback is unanimous that the program
was very beneficial. The multi-discipline approach of the program
has helped the attendees better understand corporate dynamics that
shape the work they contribute to. There is also an enhanced understanding
of how departments with seemingly distinct functions integrate to
achieve the common goal. The attendees found the case-study approach
very engaging and can now apply the increased understanding of the
drug development process in furthering their contribution and careers
at Forest.”
Yogita Desai, PhD, Asst. Director of Chemical
Manufacturing Control
Forest Laboratories, Inc.
Biotech Sector Statistics
- New York State has leveraged more than $1 billion in public
and private sector funds to grow its high technology and biotechnology
industries over the past seven years.
- Employment in the biotechnology sector has experienced steady
growth at an annual rate of 30% since 1999.
- Of more than 100 biotechnology companies in the state, 65%
are clustered around Manhattan and Long Island, in close proximity
to many world-class academic and research institutions.
back to top
|
